fashion -WSS

fashion

author：fashion 2025-09-29 19:58:21 - browse：855

STAT@ASCO 2024 — Chris Boshoff, far right, speaking at a panel with, from left, Matthew Herper of STAT, Ken Keller, Levi Garraway, and Susan Galbraith. Megan Bearder Photography

CHICAGO — The ways clinicians can treat cancers effectively are expanding, partly because technologies today are making old ideas possible, said a panel of oncology industry leaders at STAT@ASCO, STAT’s event here at the annual American Society of Clinical Oncology meeting.

“We’re seeing this expansion in modalities. We have more types of modalities that have arrived or arriving that allow us to exploit targets we’ve known about more than ever before. It’s very exciting,” said Levi Garraway, the chief medical officer of Genentech, at the event. “Things we’ve known about for a long time can be drugged for the first time or in a new, different way.”

That’s led to a surge of new medicines ranging from small molecules to cell therapies, with the potential uses of these treatments expanding into earlier lines of therapy and more cancer types each year. One example the panel singled out is the drug Enhertu, which recently received a tumor-agnostic approval from the Food and Drug Administration.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： What to know about the judge who will handle the Trump case

WSS

CDC recommends RSV monoclonal antibody for infants

CDC recommends RSV monoclonal antibody for infants

How to ethically and practically extend health care to all

Bird flu researchers hone in on Finland’s mink farms

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Illumina slashes 2023 revenue projections yet again

hotspot

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

entertainment

Tori Bowie and the unacceptable rates of Black maternal death

Physicians aren't 'burning out.' They're suffering from moral injury

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Aspartame and sugar

How one medical school became remarkably diverse

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Cancer drug shortages should be causing more outrage

Biotech startup Celsius cuts 75% of staff ahead of first trial start

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Wikipedia

The a glaring gap in research on serious mental illness and primary care

Late stage cancers on the rise after pandemic delayed screenings

Dozens dead from Maui wildfires: What we know about the victims

Idaho college killings prosecutors challenge defense's grand jury claims

Surge in Apellis stock fueled by confidence in safety of its eye drug

Heart disease in astronauts blamed on cosmic radiation

focus

Wikipedia

hotspot

hotspot